Literature DB >> 30430754

Dysregulated Translation in Neurodevelopmental Disorders: An Overview of Autism-Risk Genes Involved in Translation.

Yan-Chu Chen1, Yu-Wei Chang1, Yi-Shuian Huang1.   

Abstract

Regulated local translation-whereby specific mRNAs are transported and localized in subcellular domains where they are translated in response to regional signals-allows for remote control of gene expression to concentrate proteins in subcellular compartments. Neurons are highly polarized cells with unique features favoring local control for axonal pathfinding and synaptic plasticity, which are key processes involved in constructing functional circuits in the developing brain. Neurodevelopmental disorders are caused by genetic or environmental factors that disturb the nervous system's development during prenatal and early childhood periods. The growing list of genetic mutations that affect mRNA translation raises the question of whether aberrant translatomes in individuals with neurodevelopmental disorders share common molecular features underlying their stereotypical phenotypes and, vice versa, cause a certain degree of phenotypic heterogeneity. Here, we briefly give an overview of the role of local translation during neuronal development. We take the autism-risk gene list and discuss the molecules that (perhaps) are involved in mRNA transport and translation. Both exaggerated and suppressed translation caused by mutations in those genes have been identified or suggested. Finally, we discuss some proof-of-principle regimens for use in autism mouse models to correct dysregulated translation.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  RNA-binding protein SFARI gene; autism spectrum disorder; neurodevelopment; translational control

Mesh:

Substances:

Year:  2018        PMID: 30430754     DOI: 10.1002/dneu.22653

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  12 in total

1.  PUS7 deficiency in human patients causes profound neurodevelopmental phenotype by dysregulating protein translation.

Authors:  Sangwoo T Han; Andrew C Kim; Karolyn Garcia; Lisa A Schimmenti; Ellen Macnamara; Undiagnosed Diseases Network; William A Gahl; May C Malicdan; Cynthia J Tifft
Journal:  Mol Genet Metab       Date:  2022-02-01       Impact factor: 4.797

2.  Developmental dynamics of RNA translation in the human brain.

Authors:  Erin E Duffy; Benjamin Finander; GiHun Choi; Ava C Carter; Iva Pritisanac; Aqsa Alam; Victor Luria; Amir Karger; William Phu; Maxwell A Sherman; Elena G Assad; Naomi Pajarillo; Alexandra Khitun; Elizabeth E Crouch; Sanika Ganesh; Jin Chen; Bonnie Berger; Nenad Sestan; Anne O'Donnell-Luria; Eric J Huang; Eric C Griffith; Julie D Forman-Kay; Alan M Moses; Brian T Kalish; Michael E Greenberg
Journal:  Nat Neurosci       Date:  2022-09-28       Impact factor: 28.771

3.  Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.

Authors:  Mariah L Hoye; Lorenzo Calviello; Abigail J Poff; Nna-Emeka Ejimogu; Carly R Newman; Maya D Montgomery; Jianhong Ou; Stephen N Floor; Debra L Silver
Journal:  Elife       Date:  2022-06-28       Impact factor: 8.713

Review 4.  Decoding mixed messages in the developing cortex: translational regulation of neural progenitor fate.

Authors:  Mariah L Hoye; Debra L Silver
Journal:  Curr Opin Neurobiol       Date:  2020-10-23       Impact factor: 6.627

5.  Proteome Analysis of PC12 Cells Reveals Alterations in Translation Regulation and Actin Signaling Induced by Clozapine.

Authors:  Urszula Jankowska; Bozena Skupien-Rabian; Bianka Swiderska; Gabriela Prus; Marta Dziedzicka-Wasylewska; Sylwia Kedracka-Krok
Journal:  Neurochem Res       Date:  2021-05-23       Impact factor: 3.996

Review 6.  Implications of mRNA translation dysregulation for neurological disorders.

Authors:  Aya Jishi; Xin Qi; Helen C Miranda
Journal:  Semin Cell Dev Biol       Date:  2020-10-21       Impact factor: 7.499

7.  Maternal immune activation in mice disrupts proteostasis in the fetal brain.

Authors:  Brian T Kalish; Eunha Kim; Benjamin Finander; Erin E Duffy; Hyunju Kim; Casey K Gilman; Yeong Shin Yim; Lilin Tong; Randal J Kaufman; Eric C Griffith; Gloria B Choi; Michael E Greenberg; Jun R Huh
Journal:  Nat Neurosci       Date:  2020-12-23       Impact factor: 24.884

8.  Absence of RNA-binding protein FXR2P prevents prolonged phase of kainate-induced seizures.

Authors:  Adrian C Lo; Nicholas Rajan; Denise Gastaldo; Ludovic Telley; Muna L Hilal; Andrea Buzzi; Michele Simonato; Tilmann Achsel; Claudia Bagni
Journal:  EMBO Rep       Date:  2021-03-28       Impact factor: 8.807

9.  Maternal Benzophenone Exposure Impairs Hippocampus Development and Cognitive Function in Mouse Offspring.

Authors:  Fengzhen Cui; Qingfei Pan; Siyi Wang; Faming Zhao; Runxin Wang; Tingting Zhang; Yaying Song; Jun He; Haolin Zhang; Qiang Weng; Yang Jin; Wei Xia; Yuanyuan Li; Guo-Yuan Yang; Winnok H De Vos; Jean-Pierre Timmermans; Shunqing Xu; Yaohui Tang; Xia Sheng
Journal:  Adv Sci (Weinh)       Date:  2021-10-28       Impact factor: 16.806

Review 10.  Biological implications of genetic variations in autism spectrum disorders from genomics studies.

Authors:  Yue Zhang; Xuanshi Liu; Ruolan Guo; Wenjian Xu; Qi Guo; Chanjuan Hao; Xin Ni; Wei Li
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.